베를린, 2025년 10월 7일 -- 우리 주변 환경에서 흔히 발견되는 5mm 미만의 플라스틱 입자인 미세플라스틱이 인간의 장내 미생물(gut microbiome)을 변화시킬 수 있고, 일부 변화는 우울증 및 대장암에서 나타나는 변화 패턴과 유사한 것으로 UEG 위크 2025(UEG Week 2025)에서 6일 발표된 새로운 연구결과를 통해 확인됐다. 씨비메드(CBmed) 연구 센터가 국제 파트너들과 협력해 주도한 선구적인 코밋(COMET) 모듈 프로그램의 일환으로 진행된 마이크로원(microONE) 프로젝트에서 수행된 본 연구는 다양한 유형의 미세플라스틱이 인간 장내 미생물과 어떻게 상호작용하는지 직접 조사한 최초의 연구에 속한다. 인체 내에서 미세 및 나노 플라스틱 입자의 영향을 탐구하겠다는 마이크로원의 광범위한 사명의 일환으로 추진된 이번 연구는 미세플라스틱이 건강에 미칠 수 있는 잠재적 영향에 대한 중요한 새로운 통찰을 제공해주는 동시에 추가 연구의 필요성이 시급함을 확인시켜준다. 연구진은 건강한 자원자 5명의 대변 샘플을 이용해 체외(ex vivo) 장내 미생물 배양을 수행했다. 이어 배양체를 폴리스티렌, 폴리프로필렌,
SYDNEY, Oct. 7, 2025 -- Miroma Project Factory (MPF) has partnered with the University of Sydney to deliver a high-stakes, deeply technical modernisation of Bridge2Practise—a clinical skills training platform used by medical students and educators to simulate and assess procedural learning. Behind the scenes, Bridge2Practise was running on a five-year-old version of MeteorJS, linked to a deprecated database platform, with manual deployments, missing infrastructure documentation, and broken user flows. A growing backlog of bugs, performance issues, and unfulfilled feature reques
[ 메디채널 김갑성 기자 ] The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along with hereditary risk assessment, featuring seamless integration with additional resources. PLYMOUTH MEETING, Pa., Oct. 6, 2025 -- Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN Guidelines Navigator™ resources for breast cancer treatment as well as genetic/familia
New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health – Abu Dhabi LEHI, Utah, Oct. 6, 2025 -- Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced the appointment of Paul Jones as Chief Strategy Officer & GM, International Markets. In this newly created role, Jones will focus on accelerating GENMOR-AI, the company's proprietary platform for identifying genetic mo
HONG KONG, Oct. 6, 2025 -- For many people, finding time to exercise feels impossible. After a long day at work, commuting home, preparing meals, and taking care of family, the idea of heading to a crowded gym is exhausting. Even when you carve out time at home, traditional treadmills can be frustrating—bulky machines take up half your living room, noisy motors disrupt the household, and most require expensive subscriptions just to access the full experience. The result? Your motivation fades, workouts get skipped, and your fitness goals feel farther away. Enter the Yesoul T3S Plus Au
CENTER VALLEY, Pa., and HAMBURG, Germany, Oct. 6, 2025 -- Olympus Corporation, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, has entered into an international distribution agreement with the medical products business of U.S.-based W. L. Gore & Associates, Inc. (hereinafter Gore), a global materials science company that develops innovative products across diverse industries. The agreement allows Olympus to become the exclusive international distributor and have distribution rights of the GORE® VIABIL® Biliar
Highlights: U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 IND supported by robust preclinical safety data and comprehensive manufacturing and quality information from the previously signed Elanco licensing agreement Expedites NUZ-001 as a platform molecule with pipeline expansion potential Positions Neurizon for accelerated regulatory pathways and future partnering opportunities MELBOURNE, Australia, Oct. 6, 2025
TAIPEI, Oct. 6, 2025 -- The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), an organization focused on fostering Taiwan's biotech ecosystem, announced today that it will lead a delegation of 16 biotech industry partners from Taiwan to participate in BioJapan 2025 (Yokohama, October 8-10, 2025). Taiwan's participation in BioJapan 2025, through the Taiwan Pavilion and delegation, will serve as an impactful forum to showcase the value that Taiwan's ecosystem can bring to Japanese companies in jointly realizing the future of biotech innovation. BPIPO's Partici
This World Mental Health Day, ASICS invites everyone to take an Everyday Escape, showing you don't need to travel far or spend big to take your body and mind to a happier place. ASICS enlists Natasha Rothwell to champion movement as a more accessible and effective alternative to wellness holidays. Global study of 11,000 people shows wellness holiday benefits often fade quickly, with travel and costs adding stress. In a new Everyday Escape trial, participants who took a simple daily 15-minute movement break reported a 21% greater uplift in their overall mental state compar
HONG KONG, Oct. 4, 2025 -- Caretia, a local tech startup based at Hong Kong Science Park, today announced that its AI-powered lung cancer screening platform has achieved initial milestones and entered a new phase of development. This progress aligns closely with the direction set out in the 2025 Policy Address, where Chief Executive Mr. John Lee indicated that the government would comprehensively enhance cancer prevention and diagnosis and specifically recommended launching AI-assisted lung cancer screening. According to data from the HK Cancer Online Resource Hub, lung cancer